Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer

Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer

It remains unclear whether the accumulation of 2-deoxy-2-[<sup>18</sup>F]fluoro-<span style="font-variant: small-caps;">d</span>-glucose (<sup>18</sup>F-FDG) before the initiation of anti-programmed death-1 (PD-1) antibody can predict the outcome after i...

Full description

Bibliographic Details
Main Authors: Kosuke Hashimoto, Kyoichi Kaira, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Yu Miura, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu, Ichiei Kuji
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Journal of Clinical Medicine
Subjects:
fdg-pet
immune checkpoint inhibitor
pd-1
lung cancer
prognosis
Online Access:https://www.mdpi.com/2077-0383/9/3/725

Internet

https://www.mdpi.com/2077-0383/9/3/725

Similar Items